Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pasternak

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Folia Biologica|January 1, 1980
Tumour-associated surface antigensG Pasternak, J Milleck, L Pasternak, et al.
Archiv Fur Geschwulstforschung|January 1, 1970
[Search for tumor-specific immune reactions in leukemias in humans by the indirect membrane immunofluorescence technic]G Pasternak, B Micheel, L Pasternak, et al.
Fiziologicheskii Zhurnal SSSR Imeni I. M. Sechenova|October 1, 1986
[Mathematical model of the effect of mass transfer on heat exchange in the respiratory tract]V B Serikov, M S Ramm, G L Pasternak, et al.
Pharmacotherapy|May 20, 2016
Effect of Prophylactic Extended-Infusion Carboplatin on Incidence of Hypersensitivity Reactions in Patients with Ovarian, Fallopian Tube, or Peritoneal CarcinomasAmy L Pasternak, Nicholas A Link, Carolyn M Richardson, et al.
Journal of the American College of Clinical Pharmacy : JACCP|January 20, 2025
Assessing the knowledge, perceptions, and practices of primary care clinicians toward pharmacogeneticsEmily K Johengen, Kristen M Ward, Antoinette B Coe, et al.
JCO Oncology Practice|March 3, 2022
Survey of US Medical Oncologists' Practices and Beliefs Regarding <i>DPYD</i> Testing Before Fluoropyrimidine ChemotherapyKyoin Koo, Amy L Pasternak, N Lynn Henry, et al.
Pharmacogenetics and Genomics|September 3, 2025
Association of genetic variation with irinotecan infusion reactions and severe toxicityKelly I Nugent, Lyucheng Huang, Maisa Nazzal, et al.
Pharmacogenetics and Genomics|November 3, 2025
Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: CorrigendumKelly I Nugent, Lyucheng Huang, Maisa Nazzal, et al.
Clinical Pharmacology and Therapeutics|December 7, 2023
Risk of Toxicity From Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant AllelesJavier Granados, Amy L Pasternak, N Lynn Henry, et al.
Physiological Genomics|September 10, 2017
Germline genetic variants with implications for disease risk and therapeutic outcomesAmy L Pasternak, Kristen M Ward, Jasmine A Luzum, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Folia Biologica|January 1, 1980
Tumour-associated surface antigensG Pasternak, J Milleck, L Pasternak, et al.
Archiv Fur Geschwulstforschung|January 1, 1970
[Search for tumor-specific immune reactions in leukemias in humans by the indirect membrane immunofluorescence technic]G Pasternak, B Micheel, L Pasternak, et al.
Fiziologicheskii Zhurnal SSSR Imeni I. M. Sechenova|October 1, 1986
[Mathematical model of the effect of mass transfer on heat exchange in the respiratory tract]V B Serikov, M S Ramm, G L Pasternak, et al.
Pharmacotherapy|May 20, 2016
Effect of Prophylactic Extended-Infusion Carboplatin on Incidence of Hypersensitivity Reactions in Patients with Ovarian, Fallopian Tube, or Peritoneal CarcinomasAmy L Pasternak, Nicholas A Link, Carolyn M Richardson, et al.
Journal of the American College of Clinical Pharmacy : JACCP|January 20, 2025
Assessing the knowledge, perceptions, and practices of primary care clinicians toward pharmacogeneticsEmily K Johengen, Kristen M Ward, Antoinette B Coe, et al.
JCO Oncology Practice|March 3, 2022
Survey of US Medical Oncologists' Practices and Beliefs Regarding <i>DPYD</i> Testing Before Fluoropyrimidine ChemotherapyKyoin Koo, Amy L Pasternak, N Lynn Henry, et al.
Pharmacogenetics and Genomics|September 3, 2025
Association of genetic variation with irinotecan infusion reactions and severe toxicityKelly I Nugent, Lyucheng Huang, Maisa Nazzal, et al.
Pharmacogenetics and Genomics|November 3, 2025
Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: CorrigendumKelly I Nugent, Lyucheng Huang, Maisa Nazzal, et al.
Clinical Pharmacology and Therapeutics|December 7, 2023
Risk of Toxicity From Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant AllelesJavier Granados, Amy L Pasternak, N Lynn Henry, et al.
Physiological Genomics|September 10, 2017
Germline genetic variants with implications for disease risk and therapeutic outcomesAmy L Pasternak, Kristen M Ward, Jasmine A Luzum, et al.
Pageof 6